The latest regulatory go-ahead is likely to lend NxStage (NXTM) a competitive edge and expand its patient base with solid access to the clinical benefits associated with home hemodialysis.

NxStage said it will be working with its customers and partners to implement additional patient training for this new indication later this year and into 2018.

NxStage Medical, Inc. NXTM announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure.

NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The.

NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...